636 related articles for article (PubMed ID: 15485285)
1. Pure neuritic leprosy in India: an appraisal.
Kumar B; Kaur I; Dogra S; Kumaran MS
Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):284-90. PubMed ID: 15485285
[TBL] [Abstract][Full Text] [Related]
2. Primary neuritic leprosy: a reappraisal at a tertiary care hospital.
Mendiratta V; Khan A; Jain A
Indian J Lepr; 2006; 78(3):261-7. PubMed ID: 17120509
[TBL] [Abstract][Full Text] [Related]
3. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India.
van Brakel WH; Nicholls PG; Das L; Barkataki P; Suneetha SK; Jadhav RS; Maddali P; Lockwood DN; Wilder-Smith E; Desikan KV
Lepr Rev; 2005 Mar; 76(1):14-34. PubMed ID: 15881033
[TBL] [Abstract][Full Text] [Related]
4. The development of cutaneous lesions during follow-up of patients with primary neuritic leprosy.
Suneetha S; Sigamoni A; Kurian N; Chacko CJ
Int J Dermatol; 2005 Mar; 44(3):224-9. PubMed ID: 15807731
[TBL] [Abstract][Full Text] [Related]
5. A study on the impact of FD-MDT on 200 leprosy patients.
Vara N; Marfatiya Y
Indian J Lepr; 2005; 77(3):217-27. PubMed ID: 16353520
[TBL] [Abstract][Full Text] [Related]
6. Childhood leprosy in a tertiary-care hospital in Delhi, India: a reappraisal in the post-elimination era.
Singal A; Sonthalia S; Pandhi D
Lepr Rev; 2011 Sep; 82(3):259-69. PubMed ID: 22125934
[TBL] [Abstract][Full Text] [Related]
7. Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up.
Rao PN; Suneetha S; Pratap DV
Lepr Rev; 2011 Sep; 82(3):244-52. PubMed ID: 22125932
[TBL] [Abstract][Full Text] [Related]
8. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
Kaur I; Dogra S; Kumar B; Radotra BD
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
[TBL] [Abstract][Full Text] [Related]
9. Histopathological and clinical findings in leprosy patients with chronic neuropathic pain: a study from Hyderabad, India.
Lund C; Koskinen M; Suneetha S; Lockwood DN; Haanpää M; Haapasalo H; Hietaharju A
Lepr Rev; 2007 Dec; 78(4):369-80. PubMed ID: 18309711
[TBL] [Abstract][Full Text] [Related]
10. Childhood leprosy through the post-leprosy-elimination era: a retrospective analysis of epidemiological and clinical characteristics of disease over eleven years from a tertiary care hospital in North India.
Dogra S; Narang T; Khullar G; Kumar R; Saikia UN
Lepr Rev; 2014 Dec; 85(4):296-310. PubMed ID: 25675654
[TBL] [Abstract][Full Text] [Related]
11. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline.
Van Brakel WH; Nicholls PG; Das L; Barkataki P; Maddali P; Lockwood DN; Wilder-Smith E
Lepr Rev; 2005 Dec; 76(4):277-95. PubMed ID: 16411508
[TBL] [Abstract][Full Text] [Related]
12. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.
Shetty VP; Khambati FA; Ghate SD; Capadia GD; Pai VV; Ganapati R
Lepr Rev; 2010 Mar; 81(1):41-58. PubMed ID: 20496569
[TBL] [Abstract][Full Text] [Related]
13. Histological changes in the nerve, skin and nasal mucosa of patients with primary neuritic leprosy.
Suneetha S; Arunthathi S; Kurian N; Chacko CJ
Acta Leprol; 2000-2001; 12(1):11-8. PubMed ID: 11526636
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of uniform-MDT and WHO MDT in Pauci and Multi bacillary leprosy patients over 24 months of observation.
Rao PN; Suneetha S; Pratap DV
Lepr Rev; 2009 Jun; 80(2):143-55. PubMed ID: 19743618
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological shift in leprosy in a rural district of central India following introduction of multi-drug therapy (April 1986 to March 1992 and April 1992 to March 2002).
Pandey A; Uddin MJ; Patel R
Lepr Rev; 2005 Jun; 76(2):112-8. PubMed ID: 16038244
[TBL] [Abstract][Full Text] [Related]
16. Incidence of nerve damage in leprosy patients treated with MDT.
Solomon S; Kurian N; Ramadas P; Rao PS
Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):451-6. PubMed ID: 10347565
[TBL] [Abstract][Full Text] [Related]
17. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
Kar HK; Sharma P
Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
[TBL] [Abstract][Full Text] [Related]
18. The effect of corticosteroid usage on the bacterial killing, clearance and nerve damage in leprosy: a prospective cohort study: part 1--study design and baseline findings of 400 untreated multibacillary patients.
Khambati FA; Shetty VP; Ghate SD; Capadia GD; Pai VV; Ganapati R
Lepr Rev; 2008 Jun; 79(2):134-53. PubMed ID: 18711936
[TBL] [Abstract][Full Text] [Related]
19. Clinico-epidemiological trends of leprosy in Himachal Pradesh: a five year study.
Jindal N; Shanker V; Tegta GR; Gupta M; Verma GK
Indian J Lepr; 2009; 81(4):173-9. PubMed ID: 20704072
[TBL] [Abstract][Full Text] [Related]
20. Cytodiagnosis of primary neuritic leprosy.
Jayaseelan E; Shariff S; Rout P
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):429-34. PubMed ID: 10700918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
